BRYNJELSEN SEAN 4
4 · Eton Pharmaceuticals, Inc. · Filed Jul 18, 2022
Insider Transaction Report
Form 4
BRYNJELSEN SEAN
DirectorPresident & CEO10% Owner
Transactions
- Award
Restricted Stock Units
2022-07-12+110,000→ 110,000 total→ Common Stock (110,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
- [F2]The restricted stock units vest in four equal annual installments beginning July 12, 2023, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.